Table 3.
The spasticity and quality of life scores of individual patients at baseline (TPRE) and at different times of follow-up (TPOST and TPOST3), together with summary group (median and interquartile range).
Parameter | Patient n. | TPRE | TPOST | TPOST3 |
---|---|---|---|---|
M | 1 | 0 | 0 | 0 |
2 | 18 | 14 | 17 | |
3 | 12 | 7 | 8 | |
4 | 6 | 4 | 6 | |
5 | 0 | 0 | 0 | |
6 | 6 | 4 | 6 | |
7 | 18 | 14 | 18 | |
8 | 6 | 4 | 4 | |
9 | 0 | 0 | 0 | |
10 | 12 | 8 | 9 | |
11 | 12 | 8 | 10 | |
12 | 18 | 14 | 16 | |
13 | 12 | 8 | 12 | |
14 | 6 | 5 | 5 | |
15 | 18 | 14 | 16 | |
16 | 0 | 0 | 0 | |
9(4–13) | 6(3–9) | 7(3–13) | ||
NRS-spasticity | 1 | 2 | 1 | 2 |
2 | 0 | 0 | 0 | |
3 | 0 | 0 | 0 | |
4 | 0 | 0 | 0 | |
5 | 0 | 0 | 0 | |
6 | 1 | 1 | 1 | |
7 | 0 | 0 | 0 | |
8 | 0 | 0 | 0 | |
9 | 1 | 1 | 1 | |
10 | 1 | 1 | 1 | |
11 | 0 | 0 | 0 | |
12 | 2 | 1 | 1 | |
13 | 2 | 1 | 2 | |
14 | 1 | 1 | 1 | |
15 | 2 | 1 | 2 | |
16 | 2 | 1 | 2 | |
1(0–2) | 1(0–1.2) | 1(0–1.2) | ||
PSFS | 1 | 2 | 2 | 3 |
2 | 0 | 0 | 0 | |
3 | 2 | 1 | 3 | |
4 | 2 | 2 | 2 | |
5 | 1 | 1 | 1 | |
6 | 1 | 1 | 0 | |
7 | 1 | 1 | 0 | |
8 | 2 | 2 | 1 | |
9 | 1 | 1 | 1 | |
10 | 0 | 0 | 1 | |
11 | 0 | 0 | 1 | |
12 | 0 | 0 | 1 | |
13 | 0 | 0 | 1 | |
14 | 1 | 1 | 1 | |
15 | 1 | 1 | 0 | |
16 | 0 | 0 | 1 | |
1(0–1.2) | 1(0.1.1) | 1(0.7–1.1) | ||
SF-12 | 1 | 105 | 43 | 40 |
2 | 99 | 63 | 55 | |
3 | 88 | 65 | 45 | |
4 | 72 | 67 | 69 | |
5 | 104 | 52 | 80 | |
6 | 74 | 64 | 59 | |
7 | 71 | 59 | 57 | |
8 | 81 | 44 | 76 | |
9 | 104 | 42 | 72 | |
10 | 86 | 48 | 73 | |
11 | 94 | 50 | 76 | |
12 | 119 | 41 | 55 | |
13 | 100 | 79 | 74 | |
14 | 70 | 77 | 45 | |
15 | 118 | 57 | 74 | |
16 | 73 | 79 | 43 | |
91(74–104) | 58(47–65) | 64(52–74) |